Taxation - Reconciliation - before adoption of ASU 2023-09 (Details) - CNY (¥) ¥ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Income Taxes [Line Items] | |||
| Income before income tax | ¥ 1,408,711 | ¥ 891,414 | ¥ 205,477 |
| Tax expense at EIT tax rate of 25% | 352,178 | 222,854 | 51,369 |
| Effect of different tax rates applicable to different subsidiaries of the Group | (243,520) | (12,845) | |
| Effect of additional deduction for qualified research and development expenses | (2,240) | (6,075) | (16,323) |
| Effect on deferred tax assets due to change in tax rates | 64,030 | ||
| Non-deductible expenses | 1,539 | 5,891 | |
| Changes in valuation allowance | (6,226) | (13,260) | (27,801) |
| Income tax expense | ¥ 101,171 | ¥ 25,568 | ¥ 291 |
| Yuanbao Kechuang | |||
| Income Taxes [Line Items] | |||
| Preferential tax rate (as precent) | 0.00% | 0.00% | 15.00% |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to change in subsidiary tax rate. No definition available.
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to additional deduction for research and development expenses. No definition available.
|
| X | ||||||||||
- Definition Preferential Enterprise income tax law rate applicable to enterprises qualifying for encouraged High and New Technology Enterprises (HNTE) status under PRC tax law. No definition available.
|
| X | ||||||||||
- Details
|